By reviewing data from Northern California Kaiser Permanente, Winthrop et al. identified 18 patients with NTM disease who had received anti-TNF therapy between 2000 and 2008, and found that seven patients (39%) died with a median time between infection and death of 569 days [21]. This evidence concerns the gene TNF and infection.